[Federal Register: March 21, 2003 (Volume 68, Number 55)]
[Notices]
[Page 13920-13924]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21mr03-62]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[OPP-2003-0049; FRL-7295-5]
Tralkoxydim; Notice of Filing a Pesticide Petition to Establish a
Tolerance for a Certain Pesticide Chemical in or on Food
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the initial filing of a pesticide
petition proposing the establishment of regulations for residues of a
certain pesticide chemical in or on various food commodities.
DATES: Comments, identified by docket ID number OPP-2003-0049, must be
received on or before April 21, 2003.
ADDRESSES: Comments may be submitted electronically, by mail, or
through hand delivery/courier. Follow the detailed instructions as
provided in Unit I. of the SUPPLEMENTARY INFORMATION.
[[Page 13921]]
FOR FURTHER INFORMATION CONTACT: Jim Tompkins, Registration Division
(7505C), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone
number: (703) 305-5697; e-mail address: tompkins.jim@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to:
[sbull] Crop production (NAICS 111)
[sbull] Animal production (NAICS 112)
[sbull] Pesticide manufacturing (NAICS 311)
[sbull] Food manufacturing (NAICS 32532)
This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes have been provided to assist you and others in determining
whether this action might apply to certain entities. If you have any
questions regarding the applicability of this action to a particular
entity, consult the person listed under FOR FURTHER INFORMATION
CONTACT.
B. How Can I Get Copies of this Document and Other Related Information?
1. Docket. EPA has established an official public docket for this
action under docket identification (ID) number OPP-2003-0049. The
official public docket consists of the documents specifically
referenced in this action, any public comments received, and other
information related to this action. Although a part of the official
docket, the public docket does not include Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute. The official public docket is the collection of materials
that is available for public viewing at the Public Information and
Records Integrity Branch (PIRIB), Rm. 119, Crystal Mall 2,
1921 Jefferson Davis Hwy., Arlington, VA. This docket facility is open
from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal
holidays. The docket telephone number is (703) 305-5805.
2. Electronic access. You may access this Federal Register document
electronically through the EPA Internet under the ``Federal Register''
listings at http://www.epa.gov/fedrgstr/.
An electronic version of the public docket is available through
EPA's electronic public docket and comment system, EPA Dockets. You may
use EPA Dockets at http://www.epa.gov/edocket/ to submit or view public
use EPA Dockets at http://www.epa.gov/edocket/ to submit or view public
comments, access the index listing of the contents of the official
public docket, and to access those documents in the public docket that
are available electronically. Although not all docket materials may be
available electronically, you may still access any of the publicly
available docket materials through the docket facility identified in
Unit I.B.1. Once in the system, select ``search,'' then key in the
appropriate docket ID number.
Certain types of information will not be placed in the EPA Dockets.
Information claimed as CBI and other information whose disclosure is
restricted by statute, which is not included in the official public
docket, will not be available for public viewing in EPA's electronic
public docket. EPA's policy is that copyrighted material will not be
placed in EPA's electronic public docket but will be available only in
printed, paper form in the official public docket. To the extent
feasible, publicly available docket materials will be made available in
EPA's electronic public docket. When a document is selected from the
index list in EPA Dockets, the system will identify whether the
document is available for viewing in EPA's electronic public docket.
Although not all docket materials may be available electronically, you
may still access any of the publicly available docket materials through
the docket facility identified in Unit I.B. EPA intends to work towards
providing electronic access to all of the publicly available docket
materials through EPA's electronic public docket.
For public commenters, it is important to note that EPA's policy is
that public comments, whether submitted electronically or in paper,
will be made available for public viewing in EPA's electronic public
docket as EPA receives them and without change, unless the comment
contains copyrighted material, CBI, or other information whose
disclosure is restricted by statute. When EPA identifies a comment
containing copyrighted material, EPA will provide a reference to that
material in the version of the comment that is placed in EPA's
electronic public docket. The entire printed comment, including the
copyrighted material, will be available in the public docket.
Public comments submitted on computer disks that are mailed or
delivered to the docket will be transferred to EPA's electronic public
docket. Public comments that are mailed or delivered to the docket will
be scanned and placed in EPA's electronic public docket. Where
practical, physical objects will be photographed, and the photograph
will be placed in EPA's electronic public docket along with a brief
description written by the docket staff.
C. How and To Whom Do I Submit Comments?
You may submit comments electronically, by mail, or through hand
delivery/courier. To ensure proper receipt by EPA, identify the
appropriate docket ID number in the subject line on the first page of
your comment. Please ensure that your comments are submitted within the
specified comment period. Comments received after the close of the
comment period will be marked ``late.'' EPA is not required to consider
these late comments. If you wish to submit CBI or information that is
otherwise protected by statute, please follow the instructions in Unit
I.D. Do not use EPA Dockets or e-mail to submit CBI or information
protected by statute.
1. Electronically. If you submit an electronic comment as
prescribed in this unit, EPA recommends that you include your name,
mailing address, and an e-mail address or other contact information in
the body of your comment. Also include this contact information on the
outside of any disk or CD ROM you submit, and in any cover letter
accompanying the disk or CD ROM. This ensures that you can be
identified as the submitter of the comment and allows EPA to contact
you in case EPA cannot read your comment due to technical difficulties
or needs further information on the substance of your comment. EPA's
policy is that EPA will not edit your comment, and any identifying or
contact information provided in the body of a comment will be included
as part of the comment that is placed in the official public docket,
and made available in EPA's electronic public docket. If EPA cannot
read your comment due to technical difficulties and cannot contact you
for clarification, EPA may not be able to consider your comment.
i. EPA Dockets. Your use of EPA's electronic public docket to
submit comments to EPA electronically is EPA's preferred method for
receiving comments. Go directly to EPA Dockets at http://www.epa.gov/
edocket
, and follow the online instructions for submitting comments.
Once in the
[[Page 13922]]
system, select ``search,'' and then key in docket ID number OPP-2003-
0049. The system is an ``anonymous access'' system, which means EPA
will not know your identity, e-mail address, or other contact
information unless you provide it in the body of your comment.
ii. E-mail. Comments may be sent by e-mail to opp-docket@epa.gov,
Attention: Docket ID number OPP-2003-0049. In contrast to EPA's
electronic public docket, EPA's e-mail system is not an ``anonymous
access'' system. If you send an e-mail comment directly to the docket
without going through EPA's electronic public docket, EPA's e-mail
system automatically captures your e-mail address. E-mail addresses
that are automatically captured by EPA's e-mail system are included as
part of the comment that is placed in the official public docket, and
made available in EPA's electronic public docket.
iii. Disk or CD ROM. You may submit comments on a disk or CD ROM
that you mail to the mailing address identified in Unit I.C.2. These
electronic submissions will be accepted in WordPerfect or ASCII file
format. Avoid the use of special characters and any form of encryption.
2. By mail. Send your comments to: Public Information and Records
Integrity Branch (PIRIB) (7502C), Office of Pesticide Programs (OPP),
Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460-0001, Attention: Docket ID number OPP-2003-0049.
3. By hand delivery or courier. Deliver your comments to: Public
Information and Records Integrity Branch (PIRIB), Office of Pesticide
Programs (OPP), Environmental Protection Agency, Rm. 119, Crystal Mall
2, 1921 Jefferson Davis Hwy., Arlington, VA, Attention: Docket
ID number OPP-2003-0049. Such deliveries are only accepted during the
docket's normal hours of operation as identified in Unit I.B.1.
D. How Should I Submit CBI To the Agency?
Do not submit information that you consider to be CBI
electronically through EPA's electronic public docket or by e-mail. You
may claim information that you submit to EPA as CBI by marking any part
or all of that information as CBI (if you submit CBI on disk or CD ROM,
mark the outside of the disk or CD ROM as CBI and then identify
electronically within the disk or CD ROM the specific information that
is CBI). Information so marked will not be disclosed except in
accordance with procedures set forth in 40 CFR part 2.
In addition to one complete version of the comment that includes
any information claimed as CBI, a copy of the comment that does not
contain the information claimed as CBI must be submitted for inclusion
in the public docket and EPA's electronic public docket. If you submit
the copy that does not contain CBI on disk or CD ROM, mark the outside
of the disk or CD ROM clearly that it does not contain CBI. Information
not marked as CBI will be included in the public docket and EPA's
electronic public docket without prior notice. If you have any
questions about CBI or the procedures for claiming CBI, please consult
the person listed under FOR FURTHER INFORMATION CONTACT.
E. What Should I Consider as I Prepare My Comments for EPA?
You may find the following suggestions helpful for preparing your
comments:
1. Explain your views as clearly as possible.
2. Describe any assumptions that you used.
3. Provide copies of any technical information and/or data you used
that support your views.
4. If you estimate potential burden or costs, explain how you
arrived at the estimate that you provide.
5. Provide specific examples to illustrate your concerns.
6. Make sure to submit your comments by the deadline in this
notice.
7. To ensure proper receipt by EPA, be sure to identify the docket
ID number assigned to this action in the subject line on the first page
of your response. You may also provide the name, date, and Federal
Register citation.
II. What Action is the Agency Taking?
EPA has received a pesticide petition as follows proposing the
establishment and/or amendment of regulations for residues of a certain
pesticide chemical in or on various food commodities under section 408
of the Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a.
EPA has determined that this petition contains data or information
regarding the elements set forth in FFDCA section 408(d)(2); however,
EPA has not fully evaluated the sufficiency of the submitted data at
this time or whether the data support granting of the petition.
Additional data may be needed before EPA rules on the petition.
List of Subjects
Environmental protection, Agricultural commodities, Feed additives,
Food additives, Pesticides and pests, Reporting and record keeping
requirements.
Dated: March 13, 2003.
Debra Edwards,
Acting Director, Registration Division, Office of Pesticide Programs.
Summary of Petition
The petitioner's summary of the pesticide petition is printed below
as required by FFDCA section 408(d)(3). The summary of the petition was
prepared by the petitioner and represents the view of the petitioner.
The petition summary announces the availability of a description of the
analytical methods available to EPA for the detection and measurement
of the pesticide chemical residues or an explanation of why no such
method is needed.
Syngenta Crop Protection, Inc.
PP 6F4631
EPA has received a pesticide petition (6F4631) from Syngenta Crop
Protection, Inc., P.O. Box 18300, Greensboro, NC, 27419-8300 proposing,
pursuant to section 408(d) of the FFDCA, 21 U.S.C. 346a(d), to amend 40
CFR part 180 by establishing a tolerance for residues of tralkoxydim,
2-Cyclohexen-1-one, 2-[1-(ethoxyimino)propyl]-3-hydroxy-5-(2,4,6-
trimethylphenyl)-(9Cl), in or on the raw agricultural commodity (RAC)
barley grain, barley hay, wheat grain, and wheat hay at 0.02 parts per
million (ppm) and barley straw, wheat forage, and wheat straw at 0.05
ppm. EPA has determined that the petition contains data or information
regarding the elements set forth in section 408(d)(2) of the FFDCA;
however, EPA has not fully evaluated the sufficiency of the submitted
data at this time or whether the data support granting of the petition.
Additional data may be needed before EPA rules on the petition.
A. Residue Chemistry
1. Plant metabolism. The nature of the residue in barley, wheat,
rotational crops, and livestock is adequately understood. The residues
of concern for the tolerance expression are parent per se. Based on the
results of animal metabolism studies it is unlikely that secondary
residues would occur in animal commodities from the use of tralkoxydim
on wheat and barley. Tralkoxydim rapidly metabolizes in plants, and no
residues of parent are detected at harvest. Extensive metabolism in
grain, forage and straw occurs, with none of the individual metabolites
exceeding 3.6% total radioactive residue (TRR).
[[Page 13923]]
2. Analytical method. An adequate analytical method, gas
chromatography/mass spectrometry (GC/MS) with selected ion monitoring,
is available for enforcement purposes.
3. Magnitude of residues. Magnitude of the residue trials conducted
on spring wheat, winter wheat, and barley showed no residues above the
limit of quantification ((LOQ) = 0.02 ppm) on wheat grain, straw, hay,
or processed commodities at the harvest timing prescribed by the label.
Residues in forage ranged from <0.02 ppm to 0.03 ppm at 28 days
posttreatment. Based on the results of animal metabolism studies, it is
unlikely that significant residues would occur in secondary animal
commodities from the use of tralkoxydim on wheat and barley. The nature
of the residue in plants is adequately understood.
B. Toxicological Profile
1. Acute toxicity. EPA has established an acute reference dose
(RfD) for tralkoxydim of 0.3 milligrams/kilogram/day (mg/kg/day). This
RfD is based on the no observed adversed effect level (NOAEL) of 30 mg/
kg/day established in the rat developmental study and using an
uncertainty factor (UF) of 100 based on 10X for inter-species
extrapolation and 10X for intra-species variation.
2. Genotoxicity. Tralkoxydim was negative for mutagenic/genotoxic
effects in a gene mutation Ames Assay in bacteria, a forward gene
mutation in mouse lymphoma cells in culture, chromosome damage/in vitro
assay in human lymphocyte cells, deoxyribonucleic acid (DNA) damage
repair in vivo assay in rat hepatocytes, and chromosome damage in vivo
mouse micronuclei.
3. Reproductive and developmental toxicity. The developmental and
reproductive toxicity data do not indicate increased susceptibility of
rats or rabbits to in utero and/or postnatal exposure to tralkoxydim. A
3-generation rat reproduction study indicated a parental systemic NOAEL
of 200 ppm, 20 mg/kg/day and a systemic lowest observed averse effect
level (LOAEL) of 1,000 ppm, 100 mg/kg/day based on reduced body weights
and body weight gains in females. No reproductive toxicity was
observed. A rat developmental study with a maternal NOAEL of 30 mg/kg/
day and with a maternal LOAEL of 200 mg/kg/day based on maternal
mortality, reduced body weights, and reduced food consumption and a
developmental NOAEL of 30 mg/kg/day and a developmental LOAEL of 200
mg/kg/day based on reduced ossification of the centrum and hemicentrum,
centrum bipartite, misshapen centra and fused centra. A rabbit
developmental study with a maternal NOAEL of 20 mg/kg/day and a
maternal LOAEL of 100 mg/kg/day based on reduced food consumption and a
developmental NOAEL of 20 mg/kg/day and a developmental LOAEL of 100
mg/kg/day based on abortions and increases in late resorptions.
4. Subchronic toxicity.Tralkoxydim is of low subchronic toxicity in
21-day dermal testing.
5. Chronic toxicity. EPA has established the RfD for tralkoxydim at
0.005 mg/kg/day. This RfD is based on NOAEL of 0.5 mg/kg/day in the
chronic toxicity study in dogs with a 100-fold UF to account for
interspecies extrapolation (10x) and intraspecies variability (10x).
The Health Effects Division (HED) Cancer Assessment Review Committee
(CARC) has classified tralkoxydim in accordance with the Agency's
Proposed Guidelines for Carcinogen Risk Assessment (April 10, 1996),
``likely to being human carcinogen.'' This classification is based on
the following factors:
[sbull] Occurrence of benign Leydig cell tumors at all dose levels
with the incidences at the high dose exceeding the concurrent and
historical control range.
[sbull] Lack of an acceptable carcinogenicity study in a second
species as required by OPPTS Harmonized Guidelines.
[sbull] The relevance of the testicular tumors to human exposure
can not be discounted.
6. Animal metabolism. Based on the results of animal metabolism
studies it is unlikely that significant residues would occur in
secondary animal commodities from the use of tralkoxydim on wheat and
barley.
7. Metabolite toxicology. The nature of the residue in barley,
wheat, rotational crops, and livestock is adequately understood. The
residues of concern for the tolerance expression are parent per se.
8. Endocrine disruption. There has been no evidence of endocrine
disruption concerns with resulting from tralkoxydim use on wheat and
barley.
C. Aggregate Exposure
1. Dietary exposure. The proposed tolerances in or on RACs: Barley
grain, barley hay, wheat grain, and wheat hay at 0.02 ppm, and barley
straw, wheat forage, and wheat straw at 0.05 ppm are the first to be
established for tralkoxydim. There is no reasonable expectation of
residues of tralkoxydim occurring in meat, milk, poultry, or eggs from
its use on wheat and barley. Risk assessments were conducted by EPA to
assess dietary exposures from tralkoxydim as follows:
i. Acute exposure and risk. Acute dietary risk assessments are
performed for a food-use pesticide if a toxicological study has
indicated the possibility of an effect of concern occurring as a result
of a 1-day or single exposure. An acute dietary risk assessment was
conducted for tralkoxydim based on the NOAEL of 30 milligram/kilogram/
day (mg/kg/day) from the rat developmental study. The acute dietary
analysis using the dietary exposure evaluation model (DEEM) computer
program estimates that the distribution of single-day exposures
utilizes 0.02% of acute RfD.
ii. Chronic exposure and risk. The RfD for tralkoxydim is 0.005 mg/
kg/day. This value is based on the systemic NOAEL of 0.5 mg/kg/day in
the dog chronic feeding study with a 100-fold safety factor to account
for interspecies extrapolation (10x) and intraspecies variability
(10x).
iii. Food. A DEEM chronic exposure analysis was conducted using
tolerance levels for wheat and barley and assuming that 100% of the
crop is treated to estimate dietary exposure for the general population
and 22 subgroups. The chronic analysis showed that exposures from the
tolerance level residues in or on wheat, and barley for children 1 to 6
years old (the subgroup with the highest exposure) would be 1.4% of the
RfD. The exposure for the general U.S. population would be less than 1%
of the RfD.
A lifetime dietary carcinogenicity exposure analysis was conducted
for tralkoxydim using the proposed tolerances along with the assumption
of 100% of the crop treated and a Q* of 1.68 x 10-2 (mg/kg/
day)-1. A lifetime risk exposure analysis was also conducted
using the DEEM computer analysis. The estimated cancer risk (5 x
10-7) is less than the level that the Agency usually
considers for negligible cancer risk estimates.
iv. Drinking water. Drinking water estimated concentrations (DWECs)
for surface water (parent tralkoxydim) were calculated by EPA's
pesticide root zone model (PRIZM) computer models to be an average of
9.1 parts per billion (ppb). the DWECs for ground water based on the
computer model screening concentration in ground water (SCI-GROW2) were
calculated to be an average of .016 ppb.
2. Non-dietary exposure. There are no non-food uses of tralkoxydim
currently registered under the Federal Insecticide, Fungicide, and
Rodenticide Act (FIFRA), as amended. No non-dietary
[[Page 13924]]
exposures are expected for the general population.
D. Cumulative Effects
EPA does not have, at this time, available data to determine
whether tralkoxydim has a common mechanism of toxicity with other
substances or how to include this pesticide in a cumulative risk
assessment. Tralkoxydim is structurally a cyclohexanedione. Unlike
other pesticides for which EPA has followed a cumulative risk approach
based on a common mechanism of toxicity, tralkoxydim does not appear to
produce a toxic metabolite produced by other substances. For the
purposes of these tolerances action, therefore, EPA has not assumed
that tralkoxydim has a common mechanism of toxicity with other
substances.
E. Safety Determination
1. U.S. population--i. Acute risk. The acute dietary analysis based
on the NOAEL of 30 mg/kg/day from the rat developmental study using the
DEEM computer program estimates that the distribution of single-day
exposures utilizes 0.02% of acute RfD. The drinking water level of
comparisons (DWLOCs) for acute exposure to tralkoxydim in drinking
water calculated for females 13 + years old was 9,000 ppb. The
estimated average concentration in surface water for tralkoxydim is 9
ppb. EPA's acute DWLOC is well above the estimated exposures for
tralkoxydim in water for the subgroup of concern. For ground water, the
estimated environmental concentrations (EEC's) using the SCI-GROW model
were all less than 1 ppb.
ii. Chronic risk. A DEEM chronic exposure analysis showed that
exposure from tolerance level residues in or on wheat, and barley for
children 1 to 6 years old (the subgroup with the highest exposure)
would be 1.4% of the RfD. The exposure for the general U.S. population
would be less than 1% of the RfD. The DWLOCs for chronic exposure to
tralkoxydim in drinking water calculated for U.S. population was 150
ppb and for children (1 to 6 years old) the DWLOC was 50 ppb. The
estimated average concentration in surface water for tralkoxydim is 9
ppb. EPA's chronic DWLOC is above the estimated exposures for
tralkoxydim in water for the U.S. population and the subgroup of
concern. Conservative model estimates SCI-GROW of the concentrations of
tralkoxydim in ground water indicate that exposure will be minimal.
iii. Cancer risk. A DWLOC for cancer was calculated as 1 ppb. The
estimated concentration in surface water and ground water for
tralkoxydim for chronic exposure are 0.9 ppb, 2.8 ppb, (the 56-day
concentration)/3, and 0.1 ppb, respectively. The model exposure
estimates are less than the cancer DWLOC. EPA concludes that there is a
reasonable certainty that no harm will result from aggregate exposure
to tralkoxydim residues.
2. Infants and children. The Agency concluded that an extra safety
factor to protect infants and children is not needed based on the
following considerations: The toxicology data base is complete for the
assessment of special sensitivity of infants and children. The
developmental and reproductive toxicity data do not indicate increased
susceptibility of rats or rabbits to in utero and/or postnatal
exposure. The NOAEL used in deriving the RfD is based on changes in
liver function and morphology in male adult dogs (not developmental or
neurotoxic effects) after chronic exposure and thus are not relevant
for enhanced sensitivity to infants and children. Unrefined dietary
exposure estimates (assuming all commodities contain tolerance level
residues) overestimate dietary exposure. Model data used for ground
water and surface water source drinking water exposure assessments
result in estimates considered to be upper-bound concentrations. There
are no registered uses for tralkoxydim that could result in residential
exposures. EPA concludes that there is a reasonable certainty that no
harm will result to children from aggregate exposure to tralkoxydim
residues.
F. International Tolerances
There are no codex Alimentarius Commission (Codex) or Mexican
maximum residue levels for tralkoxydim at this time.
[FR Doc. 03-6823 Filed 3-20-03; 8:45 am]
BILLING CODE 6560-50-S